Advertisement
The Lancet Haematology
Advanced Search

About The Lancet Haematology

Register
Subscribe
Submit

About the journal

The Lancet Haematology launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice. Building on the Lancet journals' reputation for publishing high-impact research, The Lancet Haematology is expected to attain the same standing and reputation in its discipline as its sister Lancet journals, and will maintain similar high reporting standards as all Lancet titles

Reputation and Impact

The Lancet Haematology has an Impact Factor of 10.406® (2019 Journal Citation Reports®, Clarivate Analytics 2020).

Information for Authors

The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet Haematology, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email [email protected]).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Fast Track publication

The Lancet Haematology offers a Fast Track peer-review service: for articles selected for review, we aim to have comments and provide a decision within 2–4 weeks of submission. Papers accepted for publication will receive the same expert editing and production services provided for all the Lancet titles, and are published online within 8 weeks of submission on average.

Manuscript submission

To submit your manuscript to The Lancet Haematology please visit: http://www.editorialmanager.com/thelancethaematology

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Dr Lan-Lan Smith is the founding Editor of The Lancet Haematology, and was a Senior Editor at The Lancet Oncology from 2011. Prior to joining The Lancet Oncology, she gained a PhD from Cancer Research UK/University College London, UK, and held research posts in the Haemato-Oncology Section at the Institute of Cancer Research, UK, and in the Department of Haematology-Oncology at King's College London, London, UK.

Contact: [email protected]

Dr Yaiza del Pozo Martín is the Deputy Editor at The Lancet Haematology, and was a Senior Editor at The Lancet Oncology from 2017. She received a PhD in Cancer Biology and Oncology from Cancer Research UK, The Francis Crick Institute/University College London, UK, in 2015. After completing her research, she began her career in academic publishing as an Assistant Editor at Springer Nature and she gained clinical editorial experience as an Assistant Editor at BMJ Open.

Emma Cookson

Dr Emma Cookson joined The Lancet Haematology as Senior Editor in 2019. She received her PhD in mechanisms of exocytosis of von Willebrand Factor from endothelial cells from the MRC National Institute for Medical Research/Francis Crick Institute in 2012, and held a research post at the Department of Neuroscience at the University of Wisconsin-Madison. She started her career in academic publishing at Springer Nature, managing a portfolio of medical journals in the BMC Series, and was an Assistant Editor for the Lancet journals and then BMJ Open.

International Advisory Board

The advisory board of the journal consists of key opinion leaders who have lent their expertise and support to The Lancet Haematology.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

Cover image volume 7, Issue 11
November 2020
Volume 7, Issue 11